These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24975587)

  • 1. A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group.
    Doyle B; Quigley J; Lambert M; Crumlish J; Walsh C; McParland P; Culliton M; Murphy K; Fitzgerald J
    Transfus Med; 2014 Aug; 24(4):239-43. PubMed ID: 24975587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units.
    Doyle B; Quigley J; Lambert M; Crumlish J; Walsh C; Adshead S; Woolfson M; McParland P; Culliton M; Fitzgerald J
    Transfus Med; 2014 Oct; 24(5):311-5. PubMed ID: 25229430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].
    Carbonne B; Castaigne V; Cynober E; Levy R; Cortey A; Mailloux A; Larsen M; Brossard Y
    Gynecol Obstet Fertil; 2010 Mar; 38(3):205-13. PubMed ID: 20207183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study.
    Rahimi-Levene N; Chezar J; Yahalom V;
    Transfusion; 2020 Nov; 60(11):2684-2690. PubMed ID: 32770778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe fetomaternal anti-Duffy allo-immunization].
    Dufour P; Vinatier D; Bernardi C; Ezzedine M; Fonteyne G; Monnier JC; Mannessier L
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(6):809-14. PubMed ID: 1822490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO fetomaternal compatibility poses a risk for massive fetomaternal transplacental hemorrhage.
    Zizka Z; Fait T; Belosovicova H; Haakova L; Mara M; Jirkovska M; Jirasek JE; Bartosova L; Calda P
    Acta Obstet Gynecol Scand; 2008; 87(10):1011-4. PubMed ID: 18927948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
    Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
    Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)].
    Girault A; Friszer S; Maisonneuve E; Guilbaud L; Cortey A; Jouannic JM
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):119-124. PubMed ID: 28403966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: A nationwide retrospective cohort study.
    Van't Oever RM; Zwiers C; de Haas M; le Cessie S; Lopriore E; Oepkes D; Verweij EJTJ
    BJOG; 2024 May; 131(6):769-776. PubMed ID: 37743689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.